Crossref
26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES
JACC · 2026-04 · 87 (13) · A336
DOI: 10.1016/j.jacc.2026.02.830 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Jason Sangha und 1 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sangha, J., & Chattopadhyay, S. (2026). 26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES. JACC, 87(13), A336. https://doi.org/10.1016/j.jacc.2026.02.830
Vancouver
Sangha J, Chattopadhyay S. 26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES. JACC. 2026;87(13):A336. doi:10.1016/j.jacc.2026.02.830
BibTeX
@article{Sangha2026,
author = {Sangha, Jason and Chattopadhyay, Sudipta},
title = {26-A-20870-ACC LIPOPROTEIN(A) AND INCIDENT TYPE 2 DIABETES & MACE: RETHINKING RISK IN INSULIN RESISTANCE STATES},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A336},
doi = {10.1016/j.jacc.2026.02.830}
}
EUVIMED